Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Purification method for recombinant human follicle-stimulating hormone

A technology of human follicle-stimulating hormone and purification method, applied in the fields of peptide preparation, chemical instruments and methods, organic chemistry, etc., can solve the problems of affecting protein biological activity, low activity recovery rate, unclear inactivation mechanism, etc. Avoid protein precipitation and sugar shedding problems, avoid recovery loss, and ensure the effect of purity and activity

Active Publication Date: 2013-04-24
ZHEJIANG HISUN PHARMA CO LTD
View PDF8 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the heterogeneity of glycoprotein hormones on the sugar chain increases the difficulty of its chromatographic separation, which can be summed up in three aspects: low content, instability and heterogeneity
[0008] Reversed-phase chromatography requires the use of organic solvents as the elution medium for proteins. Long-term exposure of proteins to organic solvents will lead to changes in molecular structure to varying degrees, which can lead to irreversible denaturation and seriously affect the biological activity of proteins.
Metal chelation chromatography will lead to the introduction of high concentrations of metal ions into the protein solution, leading to the reduction of protein activity to varying degrees, and increasing the difficulty of removing metal ions
Hydrophobic chromatography is used for the separation of gonadotropins. The inventors found that the activity recovery rate is low, and the specific inactivation mechanism is unknown. Therefore, it is of great practical significance to develop a FSH purification process that reduces the loss of protein activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purification method for recombinant human follicle-stimulating hormone
  • Purification method for recombinant human follicle-stimulating hormone
  • Purification method for recombinant human follicle-stimulating hormone

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 Purification Approach 1 of Recombinant Human Follicle-stimulating Hormone Protein

[0041] 1) Pretreatment of cell culture supernatant containing recombinant human FSH

[0042] Clean the ultrafiltration system and perform depyrogenation treatment, concentrate the supernatant, and replace the concentrate with (0.02MTris+0.2MNaCl+0.1M methionine) buffer (pH7.0).

[0043] 2) Q sepharose F.F anion exchange chromatography

[0044] To clean the Q sepharose F.F column chromatography system and perform depyrogenation treatment, follow the steps below:

[0045] Equilibrate the chromatographic column with phase A (0.02MTris+0.2MNaCl+0.1M methionine) buffer (pH7.0) and load the sample. Under this condition, the impurities are combined on the anion exchange column, while recombinant human follicle stimulating hormone The protein does not bind to the anion exchange column, and the flow-through fraction is collected.

[0046] 3) Affinity chromatography

[0047] Clean th...

Embodiment 2

[0051] Example 2 The Purification Approach Two of Recombinant Human Follicle Stimulating Hormone Protein

[0052] 1) Pretreatment of cell culture supernatant containing recombinant human FSH

[0053] Clean the ultrafiltration system and perform depyrogenation treatment, concentrate the supernatant, and replace the concentrate with (0.02MTris+0.1MNaCl+0.01Mmethionine) buffer (pH7.2).

[0054] 2) DEAE sepharose F.F anion exchange chromatography

[0055] To clean the DEAE sepharose F.F column chromatography system and perform depyrogenation treatment, follow the steps below:

[0056] Equilibrate the chromatographic column with phase A (0.02MTris+0.1MNaCl+0.01M methionine) buffer (pH7.2) and load the sample. Under this condition, the impurities are combined on the anion exchange column, while recombinant human follicle-stimulating hormone The protein does not bind to the anion exchange column, and the flow-through fraction is collected.

[0057] 3) Affinity chromatography

[0...

Embodiment 3

[0062] Example 3 The Purification Approach Three of Recombinant Human Follicle-stimulating Hormone Protein

[0063] 1) Pretreatment of cell culture supernatant containing recombinant human FSH

[0064] Clean the ultrafiltration system and perform depyrogenation treatment, concentrate the supernatant, and replace the concentrate with (0.05MTris+0.2MNaCl+0.1M methionine) buffer (pH7.5).

[0065] 2) Q sepharose F.F anion exchange chromatography

[0066] To clean the Q sepharose F.F column chromatography system and perform depyrogenation treatment, follow the steps below:

[0067] Equilibrate the chromatographic column with phase A (0.05MTris+0.2MNaCl+0.1M methionine) buffer (pH7.5) and load the sample. Under this condition, the impurities are combined on the anion exchange column, while recombinant human follicle stimulating hormone The protein does not bind to the anion exchange column, and the flow-through fraction is collected.

[0068] 3) Affinity chromatography

[0069] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a purification method for recombinant human follicle-stimulating hormone (FSH), including anion-exchange chromatography, affinity chromatography, and gel filtration chromatography. The method is low in cost, few in steps, simple and feasible, and stable in quality; and no complicated denaturation and renaturation processes are comprised in the method, and the use of reversed phase chromatography, metal chelate chromatography or hydrophobic interaction chromatography, which have a greater impact on protein activity, is prevented. According to the method, firstly, anion exchange of flow-through mode is used for removing a large number of contaminating proteins, pigments and some residual DNA, endotoxin and host proteins, which not only protects the subsequent affinity filler, but also achieves a coarse purification and concentration enrichment; affinity media are conjugated with camel-sourced antibodies, the carrying capacity is high, and only an intact FSH molecule, instead of a single subunit, can be bound specifically, so degraded monomer subunits are better removed; and gel filtration can further remove residual DNA, endotoxin and host proteins, and can also remove protein aggregates and inadequately glycosylated FSH proteins.

Description

technical field [0001] The present invention relates to a protein purification method. Specifically, the invention discloses a new purification process of recombinant human follicle-stimulating hormone. Background technique [0002] Follicle-stimulating hormone (FSH) is the most important endocrine hormone secreted by the anterior pituitary gland that can promote and enhance the development and maturation of follicles in the ovary. It can be used to induce ovulation or superovulation, and can promote the development of sperm in men. FSH, like LH and chorionic gonadotropin (hCG), is a heterodimeric glycoprotein consisting of noncovalently bound α and β subunits, containing 92 and 111 amino acids, respectively. The sugar group is connected to the respective regions of the α and β subunits in the form of N-glycosidic bonds. Sugar accounts for 15% to 30% of glycoprotein hormone molecules, mainly including mannose, fucose and galactose, and N-acetylglucosamine. The end of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/59C07K1/22C07K1/18C07K1/16
Inventor 海岗王海彬应跃斌江海燕郭婷婷缪世伟白骅
Owner ZHEJIANG HISUN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products